Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Monday after the bell. Here’s what ...

Recently, Vertex Pharmaceuticals reported that director Suketu Upadhyay will leave its board at the 2026 annual meeting while ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now. On April 13, ...

Google has replaced its Vertex AI platform with the new Gemini Enterprise Agent Platform, marking a shift from model-centric tools to a full-stack system for building, scaling, and governing AI agents ...

The King of Prussia company's CEO said the layoffs are necessary in an industry being reshaped by new technologies, ...

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions ...

Importantly, it could work for all CF patients, whereas Vertex Pharmaceuticals' medicines target only those with certain ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) ...

Reshma Kewalramani, the first female CEO of a large biotech company, was named one of TIME’s 2026 Women of the Year.

As growth in Vertex's cystic fibrosis portfolio buoys the company amid the launch of gene therapy Casgevy, the company is feeling confident enough to boost its revenue outlook for the year. After ...